BILLS-116hr4769ih.pdf

18:56 Oct 28, 2019 4769 4769 IH 2021 6-year months December 31, 2020 monthly 2020 14 2003 the year 2019 each year 2006 1ST SESSION H. R. 4769 OCTOBER 21, 2019 year 42 U.S.C. 1395w–116(b)(1 1995

the ‘‘Medicare Prescription 4 Drug Savings

PO 00000 Frm PO 00000 Frm 00006 PO 00000 Frm 00012 PO 00000 Frm 00007 PO 00000 Frm 00005 PO 00000 Frm 00013 PO 00000 Frm 00009 PO 00000 Frm 00003 Fmt PO 00000 Frm 00015 PO 00000 Frm 00001 PO 00000 Frm 00004 PO 00000 Frm 00008 Fmt PO 00000 Frm 00002 PO 00000 Frm 00010 PO 00000 Frm 00011 Fmt

United States United Kingdom Germany Japan Australia France the United States of America Canada XVIII

Medicare Healthcare Research and Quality United Social Security SEC U.S.C. ATED tional Institutes of Health Senate the Committee on Energy and Commerce Medicare & Medicaid Services THE HOUSE OF REPRESENTATIVES Medicaid Federal Veterans Affairs Food and Drug Administration Review Project Ways and Means CONGRESS Agency the Agency for Healthcare Research Committee House of Representa-

SCHAKOWSKY

drug plan prescription drug prescription covered drugs drug medicare operated prices drugs premium price plan coverage monthly meaningful